BioMed Research International

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies


Publishing date
18 Apr 2014
Status
Published
Submission deadline
29 Nov 2013

Lead Editor

1Department of Radiology, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil

2Polytechnic Institute of Milan, Department of Physics, Milan, Italy


Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies

Description

Nuclear medicine is returning to its origin by studying more and more metabolic signals using new positron or single-photon-emitting radiopharmaceuticals. The history of nuclear medicine over the past 50 years highlights the strong link between investments in chemistry and the development of radionuclides and radiolabeled compounds. In fact, one can trace the major advances in nuclear medicine directly to research in chemistry. These advances have had a major impact on the practice of health care. According to the Society of Nuclear Medicine, 20 million nuclear medicine procedures using radiopharmaceuticals and imaging instruments are carried out in hospitals in the United States alone each year to diagnose disease and to deliver targeted treatments. These techniques have also been adopted by basic and clinical scientists in different fields (infection, immunology, gastroenterology, cardiology, oncology, neurology, psychiatry, and others) for diagnosis as well as for scientific tools. Many groups of research are now developing radiopharmaceuticals as biomarkers for new drug targets to facilitate the entry of their new drugs into the practice of health care and to objectively examine drug efficacy at a particular target relative to clinical outcome. This has created a demand for new radiopharmaceuticals and a corresponding need for scientists who are trained to develop them. We are interested in articles that describe the development and use of new radiopharmaceuticals for SPECT and PET studies, for diagnosis and treatment purposes. Potential topics include, but are not limited to:

  • Development of new radiopharmaceuticals for PET and SPECT studies
  • New radiopharmaceuticals for evaluation of autoimmune disease
  • Use of radiopharmaceuticals for inflammation/infection diagnosis
  • New role of nuclear medicine in oncology
  • Trends in radioguided surgery
  • New radiopharmaceuticals for therapy
  • New radiopharmaceuticals for PET and SPECT imaging of neurodegenerative diseases
  • New radiopharmaceuticals for PET and SPECT imaging of cardiovascular diseases

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/molecular.imaging/spect/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 426892
  • - Editorial

Radiopharmaceuticals in Nuclear Medicine: Recent Developments for SPECT and PET Studies

Bianca Gutfilen | Gianluca Valentini
  • Special Issue
  • - Volume 2014
  • - Article ID 498072
  • - Research Article

Radiation Absorbed Dose to the Basal Ganglia from Dopamine Transporter Radioligand 18F-FPCIT

William Robeson | Vijay Dhawan | ... | David Eidelberg
  • Special Issue
  • - Volume 2014
  • - Article ID 417091
  • - Review Article

Radiopharmaceutical Stem Cell Tracking for Neurological Diseases

Paulo Henrique Rosado-de-Castro | Pedro Moreno Pimentel-Coelho | ... | Lea Mirian Barbosa da Fonseca
  • Special Issue
  • - Volume 2014
  • - Article ID 369509
  • - Research Article

Preliminary Experience with Small Animal SPECT Imaging on Clinical Gamma Cameras

P. Aguiar | J. Silva-Rodríguez | ... | A. Ruibal
  • Special Issue
  • - Volume 2014
  • - Article ID 942960
  • - Review Article

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease

Oyebola O. Sogbein | Matthieu Pelletier-Galarneau | ... | Terrence D. Ruddy
  • Special Issue
  • - Volume 2014
  • - Article ID 672094
  • - Review Article

124Iodine: A Longer-Life Positron Emitter Isotope—New Opportunities in Molecular Imaging

Giuseppe Lucio Cascini | Artor Niccoli Asabella | ... | Giuseppe Rubini
  • Special Issue
  • - Volume 2014
  • - Article ID 786463
  • - Review Article

The Copper Radioisotopes: A Systematic Review with Special Interest to 64Cu

Artor Niccoli Asabella | Giuseppe Lucio Cascini | ... | Giuseppe Rubini
  • Special Issue
  • - Volume 2014
  • - Article ID 874785
  • - Review Article

SPECT- and PET-Based Approaches for Noninvasive Diagnosis of Acute Renal Allograft Rejection

Helga Pawelski | Uta Schnöckel | ... | Stefan Reuter
BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore3.600
Impact Factor2.276
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.